𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin

✍ Scribed by Clemens Leitgeb; Martin Pecherstorfer; Elke Fritz; Heinz Ludwig

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
740 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant human erythropoietin for the
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
✍ LeΓ³n, Pedro; JimΓ©nez, Miguel; Barona, Pascual; SierrasesΓΊmaga, Luis πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

## Background. Cancer is often associated with chronic anemia which frequently requires blood transfusions. This study was performed to assess the efficacy and safety of r-HuEPO therapy in children with cancer. Patients and methods. Twenty-five patients under 18 years of age with solid malignant

Recombinant erythropoietin in acute chem
Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer
✍ Beck, Maja Nenadov ;Beck, Daniel πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 444 KB

## Abstract Chemotherapy‐induced anemia in children with cancer is usually of acute onset. To investigate an alternate treatment to transfusion (Tx), we undertook a phase I‐II clinical trial of daily administrations of recombinant erythropoietin (rHuEPO). Patients with a hemoglobin (Hgb) value <75